Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00115804 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of Fluoxetine in Juvenile Fibromyalgia
A Phase 3 study of Fibromyalgia and Juvenile Primary Fibromyalgia Syndrome (JPFS), sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 3
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT00115804 is a Phase 3 study of Fibromyalgia and Juvenile Primary Fibromyalgia Syndrome (JPFS) that has completed, run by University of Cincinnati. The registered enrollment target is 6 participants, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00115804, a Phase 3 study of Fibromyalgia and Juvenile Primary Fibromyalgia Syndrome (JPFS), has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to conduct an open, pilot trial to assess the efficacy and safety of fluoxetine in the treatment of Juvenile Primary Fibromyalgia Syndrome (JPFS).
Conditions Studied
Interventions
- DRUG Fluoxetine
Study Locations (1)
Ohio
- Women's Health Research Program - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2005-06 |
| Est. Completion | 2011-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00115804
The ClinicalTrials.gov registry entry for NCT00115804 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (97% lower). The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Fibromyalgia appearing as the primary indexed condition, and to 1 intervention - of which Fluoxetine is the first listed.
NCT00115804 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00115804 about?
NCT00115804 is a clinical study titled "Safety and Efficacy of Fluoxetine in Juvenile Fibromyalgia". The purpose of this research is to conduct an open, pilot trial to assess the efficacy and safety of fluoxetine in the treatment of Juvenile Primary Fibromyalgia Syndrome (JPFS).
What is the current status of trial NCT00115804?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 6 participants. The study started on 2005-06. Estimated completion is 2011-02.
What conditions does trial NCT00115804 study?
This clinical trial studies the following conditions: Fibromyalgia, Juvenile Primary Fibromyalgia Syndrome (JPFS).
What interventions are being tested in trial NCT00115804?
The interventions under investigation include: Fluoxetine (DRUG).
Who is sponsoring clinical trial NCT00115804?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00115804 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fibromyalgia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
RECRUITING · Phase 3
-
Novel Use of (Oral) Ketotifen for the Treatment of Fibromyalgia: A Pilot Study
COMPLETED · Phase 3
-
Effects Of Pregabalin (Lyrica) On Sleep Maintenance In Subjects With Fibromyalgia
COMPLETED · Phase 3
-
Fibromyalgia TENS in Physical Therapy Study (TIPS): an Embedded Pragmatic Clinical Trial
COMPLETED · Phase 3
-
Study of Milnacipran for the Treatment of Fibromyalgia
COMPLETED · Phase 3
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.